U.S. Food and Drug Administration Approves Bristol Myers Squibb’s ZEPOSIA® (ozanimod), a New Oral Treatment for…
Tag: bristol-myers squibb
Bristol-Myers Squibb Presents Overall Survival and Safety Data From Pivotal CC-486 Study QUAZAR AML-001
(STL.News) – Bristol-Myers Squibb Company (NYSE: BMY) today announced clinical results from the QUAZAR AML-001 study,…
Bristol-Myers Squibb Receives Clearance from U.S. Federal Trade Commission for Celgene Acquisition
Company Has Now Satisfied All Regulatory Approvals for Celgene Acquisition Transaction Expected to Close on November…
Bristol-Myers Squibb-Pfizer Announce Randomized, Controlled Trial to study the Effect of Atrial Fibrillation Screening on older people Health
(STL.News) – The Bristol-Myers Squibb-Pfizer Alliance today announced the initiation of a new randomized, controlled study,…
Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes
NEW YORK (STL.News) Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb”) announced today the extension of the expiration…
Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes
New York (STL.News) – Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb”) announced today the extension of the…
Bristol-Myers Squibb Announces Agreement Between Celgene, Amgen to Divest OTEZLA® for $13.4 Billion
Agreement Contingent on FTC Consent Decree and Closing of Pending Bristol-Myers Squibb-Celgene Merger Pending Bristol-Myers Squibb-Celgene…